Companies

Amylyx Pharmaceuticals, Inc. (AMLX) SEC filings

CIK 0001658551 · Pharmaceutical Preparations (SIC 2834) · Nasdaq · incorporated in DE · fiscal year ends 12/31

Annual financials (from the company's own XBRL in its 10-K filings)

FY2025FY2024FY2023
Revenue (USD)0380.8 M22.2 M
Net income (USD)-198.4 M
Diluted EPS (USD/shares)-1.530.7-3.39

Latest filings

FiledFormDescriptionPeriod
2026-10-07442026-10-05
2026-10-05144144
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-14442026-09-10
2026-09-11144144
2026-09-11144144
2026-09-11144144
2026-09-11144144
2026-09-11144144
2026-09-088-K8-K items 1.012026-09-01
2026-09-02442026-08-31
2026-08-20442026-08-18
2026-08-20442026-08-18
2026-08-20442026-08-18
2026-08-20442026-08-18
2026-08-20442026-08-18
2026-08-208-K8-K items 1.01,9.012026-08-19
2026-08-20424B5424B5
2026-08-18424B5424B5
2026-08-188-K8-K items 8.01,9.012026-08-18
2026-08-188-K8-K items 7.01,8.01,9.012026-08-18
2026-08-0610-Q10-Q2026-06-30

Forms on file (last 1,000): 4 178, 8-K 55, 144 36, 3 17, SCHEDULE 13G/A 15, 10-Q 14, SC 13G 12, SC 13G/A 9. Source: SEC EDGAR, as filed; this page is public data and not investment advice.

For software and AI agents: the same data as JSON, per call, no account: GET https://store.agentexchange.work/gw/filings/company?ticker=AMLX (0.002 USD), /gw/filings/filings?ticker=AMLX&form=8-K, /gw/filings/facts?ticker=AMLX&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txt

Updated from EDGAR within 30 minutes of a filing. Agent Exchange